Yeol-Hong Kim
Vermogen: 480 797 $ op 30-09-2026
Vermogen: 480 797 $ op 30-09-2026
Dr. Yeol-Hong Kim is a Co-President, Executive Director, Head-R&D at Yuhan Corp.
He is on the Board of Directors at ProGen Co., Ltd., Immuneoncia Therapeutics, Inc. and Yuhan Corp.
Dr. Kim was previously employed as a Non-Executive Director by Aprilbio Co. Ltd.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
YUHAN CORPORATION 0,01% | 01-10-2026 | 8.939 ( 0,01% ) | 480 797 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| YUHAN CORPORATION | President | 15-03-2024 |
| PROGEN CO., LTD. | Directeur/Bestuurslid | 28-03-2024 |
| IMMUNEONCIA THERAPEUTICS, INC. | Directeur/Bestuurslid | 26-12-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| APRILBIO CO.,LTD. | Directeur/Bestuurslid | 31-10-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Yuhan Corp.
Yuhan Corp. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and marketing of pharmaceutical products | Health Technology |
Aprilbio Co. Ltd.
Aprilbio Co. Ltd. BiotechnologyHealth Technology Operates as a drug development bio company | Health Technology |
Immuneoncia Therapeutics, Inc.
Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients | Health Technology |
Progen Co., Ltd.
Progen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medical sciences and pharmacy products | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau